外科理论与实践2024，Vol.29Issue(1)：1-4,4.DOI:10.16139/j.1007-9610.2024.01.01
可切除胰腺癌新辅助治疗的研究及指南解读,肯定还是否定?
Research and guidelines interpretation of neoadjuvant therapy for resectable pancreatic cancer,promising or lim-ited?
摘要
Abstract
As a systemic disease,pancreatic cancer is highly malignant and has a high rate of recurrence and metastasis,which makes it particularly difficult in diagnosis,treatment and management.In recent years,with the concept of neoadjuvant therapy deeply rooted in the hearts of the people,the treatment of pancreatic cancer has increasingly emphasized the development of comprehensive and individualized treatment schemes in the whole process and multi-dimensional management of pancreatic cancer patients.However,there still remain many controversies about the application of neoadjuvant therapy for resectable pancreatic cancer.This review intended to discuss the hot topics and related controversies in the implementation of neoadjuvant therapy for patients with resectable pancreatic cancer based on domestic and foreign guidelines and the latest research progress,which may vastly promote the standardized application of neoadjuvant therapy for resectable pancreatic cancer.关键词
可切除胰腺癌/新辅助治疗/进展与争议/规范化治疗Key words
Resectable pancreatic cancer/Neoadjuvant therapy/Progress and controversies/Standardized treatment分类
医药卫生引用本文复制引用
张太平,翁桂湖,刘悦泽..可切除胰腺癌新辅助治疗的研究及指南解读,肯定还是否定?[J].外科理论与实践,2024,29(1):1-4,4.基金项目
国家自然科学基金(81972258,82272917) （81972258,82272917）
国家重点研发计划(2018YFE0118600) （2018YFE0118600）
